Opportunity Information: Apply for PAR 17 079
The Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01) funding opportunity (PAR 17-079) is a National Institutes of Health (NIH) research grant announcement led by the National Institute on Alcohol Abuse and Alcoholism (NIAAA). It focuses on health services research aimed at expanding the real-world public health impact of medications that are already approved by the U.S. Food and Drug Administration (FDA) to treat alcohol use disorder (AUD). The core idea is that effective pharmacotherapies exist, but they remain underused in routine care, so the program is looking for rigorous research that helps close the gap between evidence and everyday clinical practice.
The FOA emphasizes the need for strategies that are generalizable, scalable, and cost-effective, meaning interventions should be designed so they can work across many different settings and populations, not just in a single clinic or tightly controlled research environment. NIAAA is specifically seeking hypothesis-driven studies that test clear, measurable approaches for increasing the use of currently available AUD medications in both general medical environments (like primary care and other mainstream health systems) and specialty addiction treatment settings. In other words, the goal is not to develop new medications, but to improve how frequently and how well existing medications are actually offered, prescribed, initiated, and sustained as part of treatment.
A major theme of the announcement is addressing practical and behavioral barriers that keep AUD medications from being used more widely. Proposed research is expected to tackle factors such as acceptability (whether clinicians are comfortable prescribing and whether patients are willing to take these medications), perceived effectiveness (beliefs and expectations among providers and patients about whether medications will help), affordability (cost barriers, insurance coverage issues, and financial access), and feasibility within existing care delivery systems (how medications fit into workflows, staffing, training, clinical protocols, and organizational capacity). The intent is to identify methods that improve adoption and implementation in realistic conditions, where time constraints, competing demands, and limited resources are common.
This is an R01 mechanism, which generally supports substantial, multi-year research projects. The activity category is Health, and the associated CFDA number is 93.273. The agency listed is NIH, and the opportunity is categorized as discretionary grant funding. The original closing date shown for this opportunity is 2018-01-24, and the posting indicates a creation date of 2016-12-12. An award ceiling is not specified in the provided listing, and the expected number of awards is not shown.
Eligibility is broad and includes many types of U.S.-based organizations and government entities. Eligible applicants include state, county, city or township governments, and special district governments, as well as independent school districts. Higher education institutions are eligible, including public and state-controlled institutions of higher education and private institutions of higher education. Tribal eligibility includes federally recognized Native American tribal governments and tribal organizations that are not federally recognized tribal governments, along with tribally controlled colleges and universities. Other eligible applicants include public housing authorities and Indian housing authorities, nonprofits with and without 501(c)(3) status (excluding those that are institutions of higher education), and for-profit organizations other than small businesses, as well as small businesses and other applicant types listed in the opportunity.
The FOA also explicitly highlights additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). It also notes faith-based or community-based organizations, regional organizations, eligible federal government agencies, Indian/Native American tribal governments other than federally recognized entities, and U.S. territories or possessions as eligible.
At the same time, there are firm restrictions related to foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. Non-domestic components of U.S. organizations are not eligible to apply. In addition, foreign components, as defined by the NIH Grants Policy Statement, are not allowed under this announcement. In practice, this means the proposed work must be fully grounded in eligible U.S. applicant organizations without foreign components embedded in the project structure.
Overall, this grant opportunity is aimed at producing actionable evidence about what works to boost the uptake of FDA-approved AUD medications in everyday care. NIAAA is signaling that progress will come from implementation-focused, systems-aware research that deals directly with real barriers in clinics and communities, and that can be scaled so more patients can benefit from treatments that already have strong evidence behind them.Apply for PAR 17 079
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273.
- This funding opportunity was created on 2016-12-12.
- Applicants must submit their applications by 2018-01-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the name of this funding opportunity?
The opportunity is titled Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01) and is identified as PAR 17-079.
Which agency is offering this grant?
This is a National Institutes of Health (NIH) funding opportunity led by the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
What type of grant mechanism is this?
This opportunity uses the R01 research project grant mechanism, which generally supports substantial, multi-year research projects.
What is the main goal of this funding opportunity?
The goal is to support health services research that increases the real-world public health impact of FDA-approved medications for alcohol use disorder (AUD) by improving how often and how effectively these medications are used in routine care.
Is this opportunity focused on developing new medications for AUD?
No. The focus is not on developing new medications. The emphasis is on improving the adoption, prescribing, initiation, and sustained use of medications that are already approved by the U.S. Food and Drug Administration (FDA) for AUD.
What kind of research does NIAAA want to fund under this FOA?
NIAAA is specifically seeking hypothesis-driven studies that test clear, measurable approaches for increasing the use of currently available AUD medications under real-world conditions.
What settings should proposed studies focus on?
The FOA supports work in both:
- General medical environments (such as primary care and mainstream health systems)
- Specialty addiction treatment settings
What does the FOA mean by "generalizable, scalable, and cost-effective" strategies?
The FOA emphasizes interventions that can realistically work across many settings and populations and can be implemented with practical resource demands. The intent is to avoid approaches that only function in highly controlled or unique environments.
What implementation barriers is this program trying to address?
Proposed research is expected to directly address practical and behavioral barriers that limit use of AUD medications, including:
- Acceptability (clinician comfort prescribing and patient willingness to take medications)
- Perceived effectiveness (beliefs and expectations about whether medications will help)
- Affordability (cost barriers, insurance coverage, and financial access)
- Feasibility in real-world systems (workflows, staffing, training, clinical protocols, and organizational capacity)
What is the intended impact of the funded research?
The program aims to generate actionable evidence about what works to increase uptake of FDA-approved AUD medications in everyday care, closing the gap between established evidence and routine clinical practice so more patients can benefit.
What is the activity category for this opportunity?
The activity category listed for this opportunity is Health.
What is the CFDA number associated with this opportunity?
The associated CFDA number is 93.273.
Is this considered discretionary grant funding?
Yes. The opportunity is categorized as discretionary grant funding.
When was this opportunity created and when was it originally due?
The posting indicates a creation date of 2016-12-12 and an original closing date of 2018-01-24.
Is an award ceiling listed?
No. An award ceiling is not specified in the provided listing.
Is the expected number of awards provided?
No. The expected number of awards is not shown in the provided listing.
Who is eligible to apply?
Eligibility is broad and includes many U.S.-based organization types and government entities, including:
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Public housing authorities and Indian housing authorities
- Nonprofits with 501(c)(3) status (excluding institutions of higher education)
- Nonprofits without 501(c)(3) status (excluding institutions of higher education)
- For-profit organizations other than small businesses
- Small businesses
- U.S. territories or possessions
Are Tribal entities eligible to apply?
Yes. Eligible applicants include:
- Federally recognized Native American tribal governments
- Tribal organizations that are not federally recognized tribal governments
- Tribally Controlled Colleges and Universities
Are minority-serving institutions specifically mentioned as eligible?
Yes. The FOA explicitly highlights eligibility for several categories, including:
- Alaska Native and Native Hawaiian Serving Institutions
- Asian American Native American Pacific Islander Serving Institutions (AANAPISISs)
- Hispanic-serving Institutions
- Historically Black Colleges and Universities (HBCUs)
- Tribally Controlled Colleges and Universities (TCCUs)
Are faith-based or community-based organizations eligible?
Yes. The FOA notes that faith-based or community-based organizations are among the eligible applicant types.
Are federal agencies eligible applicants?
Yes. The FOA includes eligible federal government agencies among the eligible applicant categories.
Can non-U.S. (foreign) organizations apply?
No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply under this announcement.
Can a U.S. organization apply if the project includes a foreign component?
No. The FOA states that foreign components are not allowed (as defined by the NIH Grants Policy Statement). It also states that non-domestic components of U.S. organizations are not eligible to apply.
What does it mean that foreign components are not allowed?
Based on the FOA language provided, it means the proposed work must be fully grounded in eligible U.S. applicant organizations and cannot include a foreign component as part of the project structure.
What is the central problem this FOA is trying to solve?
The FOA is designed around the idea that effective AUD medications already exist, but they remain underused in routine care. The program supports research to close the gap between evidence and everyday clinical practice.
What kinds of real-world constraints does the FOA expect researchers to account for?
The FOA emphasizes realistic conditions where time constraints, competing demands, and limited resources are common, and encourages research that fits within existing care delivery systems and organizational capacity.
Browse more opportunities from the same category: Health
Next opportunity: Nutrition and Alcohol-Related Health Outcomes (R21)
Previous opportunity: Tools for Clinical Care and Management of Alzheimers Disease (AD) and Its Comorbidities (R41/R42)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 17 079
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 17 079) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIMH Short Courses for Mental Health-Related Research Education (R25) Apply for PAR 17 082 Funding Number: PAR 17 082 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01) Apply for RFA MH 17 614 Funding Number: RFA MH 17 614 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Mentoring Networks for Mental Health Research Education (R25) Apply for PAR 17 080 Funding Number: PAR 17 080 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIMH Research Education Programs for Psychiatry Residents (R25) Apply for PAR 17 081 Funding Number: PAR 17 081 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Eradication of HIV-1 from Central Nervous system Reservoirs (R01) Apply for PA 17 084 Funding Number: PA 17 084 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIBIB Biomedical Technology Resource Centers (P41) Apply for PAR 17 083 Funding Number: PAR 17 083 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Request for Comment on USAID's Burma Planned Maternal, Neonatal, and Child Health-Health Systems Strengthening (MNCH-HSS) activity Apply for RFI 17 MNCH ACTIVITY BURMA Funding Number: RFI 17 MNCH ACTIVITY BURMA Agency: Burma USAID - Rangoon Category: Health Funding Amount: $30,000,000 |
| Exploratory Analyses of Existing Cohorts, Data Sets, and Stored Biospecimens to Address Clinical Aging Research Questions (R21) Apply for PA 17 089 Funding Number: PA 17 089 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Secondary Analyses of Existing Cohorts, Data Sets and Stored Biospecimens to Address Clinical Aging Research Questions (R01) Apply for PA 17 088 Funding Number: PA 17 088 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing Investigators' Research Award (R35) Apply for PAR 17 094 Funding Number: PAR 17 094 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Planning for Non-Communicable Diseases and Disorders Research Training Programs in Low and Middle Income Countries (D71) Apply for PAR 17 097 Funding Number: PAR 17 097 Agency: National Institutes of Health Category: Health Funding Amount: $46,000 |
| NEI Translational Research Program (TRP) to Develop Novel Therapies and Devices for the Treatment of Visual System Disorders (R24) Apply for PAR 17 099 Funding Number: PAR 17 099 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| National Centers for Cryoelectron Microscopy (U24) Apply for RFA RM 17 002 Funding Number: RFA RM 17 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Efficacy Clinical Trials (U01) Apply for PAR 17 102 Funding Number: PAR 17 102 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21) Apply for PA 17 103 Funding Number: PA 17 103 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R01) Apply for PA 17 104 Funding Number: PA 17 104 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01) Apply for PA 17 113 Funding Number: PA 17 113 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01) Apply for PA 17 114 Funding Number: PA 17 114 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42) Apply for PAR 17 107 Funding Number: PAR 17 107 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44) Apply for PAR 17 108 Funding Number: PAR 17 108 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 17 079", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
